HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists
Abstract
Authors
J Sharpe K.M. Zimmerman Savill D Gentile N Moffett RN Bone Y Jeune-Smith B Feinberg